FindTrial
Sign In

Clinical use of Sherlock-3CG® for positioning peripherally inserted central catheter: a prospective observational study

Clinical use of Sherlock-3CG® for positioning peripherally inserted central catheter: a prospective observational study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095282
Enrollment
Unknown
Registered
2025-01-04
Start date
2024-12-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult patients requiring PICC catheterization

Interventions

Traditional intracavitary electrocardiogram localization group:NA
Sherlock 3CG TCS positioning methodgroup:NA

Sponsors

Guiqian International General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1: They are between 18 and 95 years old 2: It meets the catheterization indication and requires PICC insertion 3: The surface electrocardiogram has a recognizable P wave 4: Voluntarily sign informed consent

Exclusion criteria

Exclusion criteria: 1: Contraindications for catheterization 2: Patients with coagulation mechanism disorders 3: There are physical disabilities, scoliosis, etc. that affect height acquisition 4: Patients with atrial fibrillation and arrhythmia

Design outcomes

Primary

MeasureTime frame
Accuracy;user friendliness;—

Secondary

MeasureTime frame
safety;—

Countries

China

Contacts

Public ContactHongmei Huang

Guiqian International General Hospital

985203274@qq.com+86 138 8367 0478

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026